Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutramed Pharmaceuticals is an India-based private pharmaceutical company incorporated in 2001 and registered in New Delhi. Publicly available evidence suggests it is a small, unlisted commercial-stage company that markets finished pharmaceutical products rather than a clinical-stage biotech developer. Third-party medicine directories list products associated with the company including Fast-x Gel, Nucal Tablets, Oscirol-C Tablets, Dase DP, and Cartimax, indicating a focus on analgesic, anti-inflammatory, and supplement-style formulations. There is little evidence of a disclosed R&D pipeline, proprietary platform technology, or active clinical development programs in the biotech sense. Overall, the company appears to operate as a small branded/generic pharma marketer in India with limited public disclosure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutramed Pharmaceuticals.